IP Library Granted Patent US 7,615,646
Granted Patent B2
US 7,615,646 · App. 10/513,141 · Granted Nov 10, 2009

Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups

Assignees: Carnegie Mellon University; GE Healthcare UK Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,646
App. No.
10/513,141
Granted
Nov 10, 2009
Kind
B2
Abstract

This invention relates to the functionalized cyanine dyes and more particularly, to the synthesis of chiral 3-substituted 2,3′-dymethyl-3H-indole and its derivatives as intermediates for preparation of cyanine dyes, to methods of preparing these dyes and the dyes so prepared.

Claims (36)

1. A compound of the following general formula (XIII)

wherein R a , R c , R d and R f are independently selected from hydrogen, halogen and —SO 3 − ;

R b is selected from V or L-V, where L is a bond or C 1-22 straight or branched alkyl, optionally containing 0, 1 or 2 unsaturations or unsaturated pendent or interchain groups selected from alkenyl, alkynyl and aryl groups; and V is selected from hydrogen, —SO 3 − , —COOH and a reactive group;

R e is hydrogen;

T is

wherein each L and V are independently as defined above;

Y is selected from the group consisting of O, S, —CH═CH—, >C(CH 3 ) 2 , and

wherein each L and V are independently as defined above;

Z a and Z b are, independently, fused

n is an integer from 1-4; and p, u, v and r are independently an integer from 0-4, wherein at least one group -L-V in groups T and/or Y is a substituted alkyl group.

2. A compound of the following general formula (XIII)

wherein R a , R c , R d and R f are independently selected from hydrogen, halogen and —SO 3 − ;

R b is selected from V or L-V, where L is a bond or C 1-22 straight or branched alkyl, optionally containing 0, 1 or 2 unsaturations or unsaturated pendent or interchain groups selected from alkenyl, alkynyl and aryl groups; and V is selected from hydrogen, —SO 3 − , —COOH and a reactive group;

R e is hydrogen;

T is

wherein each L and V are independently as defined above;

Y is selected from the group consisting of O, S, —CH═CH, <C(CH 3 ) 2 , and

wherein each L and V are independently as defined above;

Z a and Z b are, independently, fused

n is an integer from 1-4; and p, u, v and r are independently an integer from 0-4, wherein said at least one group -L-V in groups T and/or Y is selected from a carboxyalkyl group, a sulfoalkyl group and a reactive group.

3. A compound of claim 1 or claim 2 wherein said reactive group is selected from:

where n is an integer of 1-10, and Q and W are leaving groups.

4. A method for detecting acidic or basic conditions comprising contacting a compound according to claim 1 or claim 2 with a composition suspected of being acidic or basic and detecting the fluorescence of said compound as an indicator of said acidic or basic conditions.

5. The method according to claim 4 wherein said composition comprises an intracellular environment.

6. A compound selected from the group consisting of:

i) 2-{(1E,3E,5E)-5-[3-(5-carboxypentyl)-3-methyl-5-sulfo-1,3-dihydro-2H-indol-2-ylidene]penta-1,3-dienyl}-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium;

ii) 3-(5-carboxypentyl)-2-[(1E,3E,5E)-5-(5,7-dichloro-3,3-dimethyl-1,3-dihydro -2H-indol-2-ylidene)penta-1,3-dienyl]-3-methyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium;

iii) 2-{(1E,3E,5E)-5-[3-(5-carboxypentyl)-3-methyl-5-sulfo-1,3-dihydro-2H-indol-2-ylidene]penta-1,3-dienyl}-5-chloro-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium;

iv) 3-(5-carboxypentyl)-2-[(1E,3E,5E)-5-(7-chloro-3,3-dimethyl-5-sulfo- 1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3-methyl-5-sulfo-1 -(4-sulfobutyl)-3H -indolium; and

v) 3-(5-carboxypentyl)-3-methyl-2-{(1E,3E,5E)-5-[3-methyl-5-sulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-indol-2-ylidene]penta-1,3-dienyl}-5-sulfo-1-(4-sulfobutyl)-3H -indolium.

7. A method for labelling and detecting a component of an aqueous liquid comprising:

a) adding to said liquid containing said component a compound of claim 1 or claim 2 which compound is reactive with said component;

b) reacting said compound with said component so that said compound becomes bound to and thereby labels said component; and

c) detecting said labeled component by an optical method.

8. The method of claim 7 wherein said component is selected from any one of an antibody, protein, peptide, enzyme substrate, hormone, lymphokine, metabolite, receptor, antigen, hapten, lectin, avidin, streptavidin, toxin, carbohydrate, oligosaccharide, polysaccharide, nucleic acid, derivatized deoxy nucleic acid, DNA fragment, RNA fragment, derivatized DNA fragment, derivatized RNA fragment, nucleoside, nucleotide, natural drug, synthetic drug, virus particle, bacterial particle, virus component, yeast component, blood cell, blood cell component, plasma component, serum component, biological cell, noncellular blood component, bacteria, bacterial component, natural or synthetic lipid vesicle, poison, environmental pollutant, polymer, polymer particle, glass particle, glass surface, plastic particle, plastic surface, polymer membrane, conductor or semiconductor.

9. A compound of claim 3 wherein Q and W are independently selected from the group consisting of l, Br and Cl.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jun 17, 2016
From: CARNEGIE-MELLON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038943/0199 →
CONFIRMATORY LICENSE Recorded Feb 22, 2016
From: CARNEGIE MELLON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 037785/0522 →
CHANGE OF NAME Recorded Sep 25, 2009
From: AMERSHAM BIOSCIENCES UK LIMITED
To: GE HEALTHCARE UK LIMITED
Reel/Frame 023285/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2005
From: MUJUMDAR, RATNAKER B.; WEST, RICHARD MARTIN
To: CARNEGIE MELLON UNIVERSITY; AMERSHAM BIOSCIENCES UK LIMITED
Reel/Frame 016414/0141 →
Continuity (2)
Provisional Application 6037910700 · May 10, 2002
Related Publication 20060051758A1 · Mar 9, 2006